首页> 美国卫生研究院文献>Cough (London England) >A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers
【2h】

A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers

机译:佐芬普利和雷米普利对健康志愿者咳嗽反射和气道炎症的交叉随机比较研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPersistent dry cough is a well known unwanted effect of Angiotensin-Converting Enzyme inhibitors (ACE-i). Animal studies have shown that the ACE-i zofenopril has a less tussigenic effect compared to the widely used ACE-i ramipril. The aim of this study was to compare cough sensitivity to inhaled tussigens, as well as spontaneous cough in response to the administration of zofenopril and ramipril in healthy volunteers; pharmacokinetic (PK) data of both zofenopril and ramipril, as well as their respective active forms, zofenoprilat and ramiprilat, was also collected.
机译:背景持续性干咳是血管紧张素转换酶抑制剂(ACE-i)众所周知的不良作用。动物研究表明,与广泛使用的ACE-i雷米普利相比,ACE-i zofenopril具有较小的致毒作用。这项研究的目的是比较健康志愿者对吸入的毒杀剂的咳嗽敏感性以及对服用佐芬普利和雷米普利的自发性咳嗽的敏感性。还收集了佐芬普利和雷米普利的药代动力学(PK)数据以及它们各自的活性形式左芬普利拉和雷米普利拉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号